Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soligenix (SNGX)
NASDAQ:SNGX
Soligenix (SNGX) Stock Price & Analysis
537 Followers
SNGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.42 - $10.93
Previous Close$0.5
Volume178.77K
Average Volume (3M)129.06K
Market Cap
$4.94M
Enterprise Value-$5.09M
Total Cash (Recent Filing)$13.16M
Total Debt (Recent Filing)$3.13M
Price to Earnings (P/E)-0.2
Beta0.48
Next Earnings
Nov 10, 2023EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.04
Shares Outstanding9,841,854
10 Day Avg. Volume54,355
30 Day Avg. Volume129,055
Standard Deviation0.28
R-Squared0.09
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.91
Price to Sales (P/S)23.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-5.11
Enterprise Value/Gross Profit-12.78
Enterprise Value/Ebitda0.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Soligenix News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNGX FAQ
What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $0.42 and its highest was $10.93 in the past 12 months.
What is Soligenix’s market cap?
Currently, no data Available
When is Soligenix’s upcoming earnings report date?
Soligenix’s upcoming earnings report date is Nov 10, 2023 which is in 22 days.
How were Soligenix’s earnings last quarter?
Soligenix released its earnings results on Aug 21, 2023. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.27 by $0.05.
Is Soligenix overvalued?
According to Wall Street analysts Soligenix’s price is currently Overvalued.
Does Soligenix pay dividends?
Soligenix does not currently pay dividends.
What is Soligenix’s EPS estimate?
Soligenix’s EPS estimate is -$0.14.
How many shares outstanding does Soligenix have?
Soligenix has 9,841,854 shares outstanding.
What happened to Soligenix’s price movement after its last earnings report?
Soligenix reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.27. Following the earnings report the stock price went up 2.222%.
Which hedge fund is a major shareholder of Soligenix?
Currently, no hedge funds are holding shares in SNGX
---
Soligenix Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.60%
12-Months-Change
Fundamentals
Return on Equity
-194.30%
Trailing 12-Months
Asset Growth
-35.13%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Soligenix
Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.
---
Top 5 ETFs holding SNGX
iShares Core S&P Total U.S. Stock Market ETF
$595.52
Up to five ETFs with an Outperform Smart Score that hold SNGX. The ETFs are listed according to market value of SNGX within the ETF
---